Skip to main content

Table 3 Results of linearity

From: Method development and validation for Cabotegravir and Rilpivirine by using HPLC and its degradants are characterized by LCMS and FTIR

S. no

Rilpivirine

Cabotegravir

Concentration (µg/ml)

Area

Concentration (µg/ml)

Area

1

30.00

270,078

20.00

143,686

2

75.00

637,392

50.00

358,414

3

150.00

1,273,025

100.00

679,383

4

300.00

2,544,502

200.00

1,311,917

5

375.00

3,060,044

250.00

1,610,677

6

450.00

3,643,429

300.00

1,914,838